References

  1. Turner CE, Elsohly MA, Boeren EG. Constituents of cannabis sativa L. XVII: a review of the natural constituents. J Nat Products. 1980; 43(2):169-185. PubMed | Google Scholar

  2. United Nations Office on Drugs and Crime.2010. http://www.unodc.org/documents/wdr/WDR_2010/World_Drug_Report_2010_lo-res.pdf. Accessed 21 December 2012.

  3. Bolla KI, Brown K, Eldreth D, Tate K, Cadet JL. Dose related neurocognitive effects of marijuana use. Neurology. 2002; 59(9):1337-1343. PubMed | Google Scholar

  4. Gordon E, Devinsky O. Alcohol and Marijuana: Effects on epilepsy and use by patients with epilepsy. Epilepsia. 2001; 42(10):1266-1272. PubMed | Google Scholar

  5. Gross DW, Hamm J, Ashworth NL, Quigley D. Marijuana use and epilepsy: prevalence in patients of a tertiary care epilepsy center. Neurology. 2004; 62(11): 2095-2097. PubMed | Google Scholar

  6. Canas N, Breia P, Soares P, Saraiva P, Clado S, Jordao C, Vale J. The electroclinical-imagiological spectrum and long-term outcome of transient peri-ictal MRI abnormalities. Epilepsy Research. 2010; 91(2-3):240-252. PubMed | Google Scholar

  7. Caplan LR, Hier DB, Banks G. Current concepts of cerebrovascular disease. Stroke: stroke and drug abuse. Stroke. 1982; 13(6):869-892. PubMed | Google Scholar

  8. Zachariah SB. Stroke after heavy marijuana smoking. Stroke. 1991; 22(3):406-408. PubMed | Google Scholar

  9. Herning RI, Better WE, Tate K, Cadet JL. Cerebrovascular perfusion in marijuana users during a month of monitored abstinence. Neurology. 2005; 64(3):488-493. PubMed | Google Scholar